TC BioPharm (Holdings) PLC (TCBP)
1.46
+0.01
(+0.69%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
TC BioPharm Net Income (TTM): -7.333M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -7.333M |
June 30, 2023 | -1.705M |
Date | Value |
---|---|
December 31, 2022 | -1.503M |
June 30, 2022 | -3.057M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-7.333M
Minimum
Dec 2023
-1.503M
Maximum
Dec 2022
-3.399M
Average
-2.381M
Median
Net Income (TTM) Benchmarks
Adaptimmune Therapeutics PLC | -113.87M |
Biodexa Pharmaceuticals Plc | -8.826M |
NuCana PLC | -34.32M |
Autolus Therapeutics PLC | -208.38M |
Mereo BioPharma Group PLC | -29.47M |